8/23/2013

Israeli firm InSightec has secured approval to market its ExAblate ultrasound technology in Canada. The MRI-guided device, which uses highly focused beam to ablate tissue, has been approved in that country for treating metastatic bone tumors as well as benign uterine tumors.

Related Summaries